{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:39:27Z","timestamp":1760834367991,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jocn.2019.06.015","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T08:58:53Z","timestamp":1560848333000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The clinical characteristics of adult cryptococcal meningitis patients who died within one year of treatment with a focus on those with early mortality"],"prefix":"10.1016","volume":"67","author":[{"given":"Wan-Chen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yi","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ren","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Neng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.06.015_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2018.06.044","article-title":"The prognostic factors of HIV-negative adult cryptococcal meningitis with a focus on cranial MRI-based neuroimaging findings","volume":"55","author":"Tsai","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2019.06.015_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2019.06.015_b0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of Cryptococcal disease: 2010 update by the infectious disease society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jocn.2019.06.015_b0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s40475-015-0046-y","article-title":"Cryptococcal meningitis: diagnosis and management update","volume":"2","author":"Abassi","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.jocn.2019.06.015_b0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/jhin.1998.0610","article-title":"The prognostic factors of cryptococcal meningitis in HIV-negative patients","volume":"42","author":"Lu","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jocn.2019.06.015_b0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1468-1331.2007.01852.x","article-title":"Time course of cerebral hemodynamics in cryptococcal meningitis in HIV-negative adults","volume":"14","author":"Chang","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2019.06.015_b0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1468-1331.2008.02091.x","article-title":"Cerebrospinal fluid 14-3-3-gamma protein level in eight HIV-negative cryptococcal meningitis adults","volume":"15","author":"Chang","year":"2008","journal-title":"Eur J Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.jocn.2019.06.015_b0040","first-page":"S26","article-title":"Clinical characteristics and outcomes of patient with cryptococcal meningoencephalitis in a resource-limited setting","volume":"97","author":"Chayakulkeeree","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jocn.2019.06.015_b0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/01616412.2018.1447319","article-title":"Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: retrospective cohort therapy","volume":"40","author":"Xu","year":"2018","journal-title":"Neurol Res"},{"key":"10.1016\/j.jocn.2019.06.015_b0050","first-page":"1122","article-title":"Long term mortality and disability in cryptococcal meningitis: a systematic literature review","volume":"66","author":"Pasquier","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jocn.2019.06.015_b0055","first-page":"56","article-title":"Clinical outcomes of cryptococcal meningitis among HIV-infected patients in the era of antiretroviral therapy","volume":"48","author":"Kobayashi","year":"2017","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.jocn.2019.06.015_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067311","article-title":"A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in Blantyre, Malawi","volume":"8","author":"Rothe","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.jocn.2019.06.015_b0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0195-6701(98)90021-4","article-title":"The prognostic factors of adult-gram-negative bacillary meningitis","volume":"40","author":"Lu","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jocn.2019.06.015_b0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s15010-001-1100-3","article-title":"The prognostic factors of adult tuberculous meningitis","volume":"29","author":"Lu","year":"2001","journal-title":"Infection"},{"key":"10.1016\/j.jocn.2019.06.015_b0075","first-page":"CD009012","article-title":"Mbuagbaw L. Optimal timing for the antiretrovirus therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis","volume":"28","author":"Njei","year":"2013","journal-title":"Cochrane Database Sys Rev"},{"issue":"3","key":"10.1016\/j.jocn.2019.06.015_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119090","article-title":"Risk factors for invasive Cryptococcus neoformans diseases: a case \u2013control study","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2019.06.015_b0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40409-015-0012-0","article-title":"Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan","volume":"21","author":"Chen","year":"2015","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.jocn.2019.06.015_b0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00005792-198303000-00003","article-title":"Cryptococcemia","volume":"62","author":"Perfect","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jocn.2019.06.015_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archneur.1978.00500270061014","article-title":"Cryptococcal meningitis. Cure despite cryptoccemia","volume":"35","author":"Roberts","year":"1978","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2019.06.015_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0732-8893(99)00137-6","article-title":"Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan","volume":"36","author":"Chen","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jocn.2019.06.015_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: The CryptoA\/D Study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jocn.2019.06.015_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003847","article-title":"Genotype diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across southen Africa","volume":"9","author":"Beale","year":"2015","journal-title":"PloS Negl Trop Dis"},{"key":"10.1016\/j.jocn.2019.06.015_b0115","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00311-15","article-title":"Dromer F, The French Cryptococcosis Study Group. Cryptococcosis serotypes impact outcome and provide evidence of Cryptococcus neoformans speciation","volume":"6","author":"Desnos-Ollivier","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.jocn.2019.06.015_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/22221751.2018.1562849","article-title":"Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil","volume":"8","author":"Ponzio","year":"2019","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jocn.2019.06.015_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00196-12","article-title":"Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis","volume":"3","author":"Wiesner","year":"2012","journal-title":"MBio"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:18:00Z","timestamp":1760822280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586819300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"alternative-id":["S0967586819300116"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.06.015","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical characteristics of adult cryptococcal meningitis patients who died within one year of treatment with a focus on those with early mortality","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}